TimesSquare Capital Management LLC lifted its position in shares of AMETEK, Inc. (NYSE:AME – Free Report) by 8.0% in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 259,937 shares of the technology company’s stock after acquiring an additional 19,270 shares during the period. TimesSquare Capital Management LLC owned approximately 0.11% of AMETEK worth $47,038,000 as of its most recent filing with the Securities & Exchange Commission.
Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Bares Capital Management Inc. purchased a new stake in shares of AMETEK during the first quarter valued at $26,000. ST Germain D J Co. Inc. grew its stake in shares of AMETEK by 628.6% in the second quarter. ST Germain D J Co. Inc. now owns 153 shares of the technology company’s stock worth $28,000 after acquiring an additional 132 shares during the period. NewSquare Capital LLC grew its stake in shares of AMETEK by 129.7% in the second quarter. NewSquare Capital LLC now owns 170 shares of the technology company’s stock worth $31,000 after acquiring an additional 96 shares during the period. Annis Gardner Whiting Capital Advisors LLC lifted its position in AMETEK by 57.7% during the first quarter. Annis Gardner Whiting Capital Advisors LLC now owns 194 shares of the technology company’s stock valued at $33,000 after purchasing an additional 71 shares during the period. Finally, SouthState Corp boosted its holdings in AMETEK by 47.4% in the second quarter. SouthState Corp now owns 202 shares of the technology company’s stock worth $37,000 after purchasing an additional 65 shares during the last quarter. 87.43% of the stock is owned by institutional investors.
Wall Street Analysts Forecast Growth
A number of research firms have recently issued reports on AME. Weiss Ratings restated a “buy (b)” rating on shares of AMETEK in a research note on Wednesday, October 8th. Mizuho raised their target price on AMETEK from $212.00 to $225.00 and gave the stock an “outperform” rating in a research report on Friday, August 1st. Royal Bank Of Canada increased their price objective on shares of AMETEK from $212.00 to $229.00 and gave the stock an “outperform” rating in a research note on Friday, October 31st. Morgan Stanley boosted their target price on shares of AMETEK from $185.00 to $198.00 and gave the company an “equal weight” rating in a research report on Friday, August 8th. Finally, Wall Street Zen upgraded shares of AMETEK from a “hold” rating to a “buy” rating in a research report on Saturday, November 1st. Eight investment analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $211.00.
Insider Transactions at AMETEK
In other news, insider Ronald J. Oscher sold 26,290 shares of AMETEK stock in a transaction that occurred on Friday, October 31st. The shares were sold at an average price of $200.05, for a total transaction of $5,259,314.50. Following the sale, the insider owned 40,226 shares in the company, valued at $8,047,211.30. This trade represents a 39.52% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. 0.57% of the stock is currently owned by company insiders.
AMETEK Price Performance
Shares of NYSE:AME opened at $197.55 on Wednesday. The firm’s 50 day simple moving average is $188.40 and its two-hundred day simple moving average is $182.70. The company has a debt-to-equity ratio of 0.15, a current ratio of 1.63 and a quick ratio of 1.04. The company has a market capitalization of $45.48 billion, a P/E ratio of 31.81, a P/E/G ratio of 2.64 and a beta of 1.12. AMETEK, Inc. has a 1-year low of $145.02 and a 1-year high of $204.15.
AMETEK (NYSE:AME – Get Free Report) last released its earnings results on Thursday, October 30th. The technology company reported $1.89 earnings per share for the quarter, beating analysts’ consensus estimates of $1.76 by $0.13. The company had revenue of $1.89 billion for the quarter, compared to analysts’ expectations of $1.81 billion. AMETEK had a net margin of 20.60% and a return on equity of 16.53%. AMETEK’s revenue for the quarter was up 10.8% on a year-over-year basis. During the same quarter in the previous year, the company earned $1.66 EPS. AMETEK has set its Q4 2025 guidance at 1.900-1.950 EPS. FY 2025 guidance at 7.320-7.370 EPS. Research analysts expect that AMETEK, Inc. will post 7.15 EPS for the current fiscal year.
AMETEK Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Friday, December 19th. Shareholders of record on Friday, December 5th will be paid a $0.31 dividend. This represents a $1.24 annualized dividend and a yield of 0.6%. The ex-dividend date is Friday, December 5th. AMETEK’s dividend payout ratio is presently 19.56%.
AMETEK Profile
AMETEK, Inc manufactures and sells electronic instruments and electromechanical devices in the North America, Europe, Asia, and South America, and internationally. The company's EIG segment offers advanced instruments for the process, aerospace, power, and industrial markets; process and analytical instruments for the oil and gas, petrochemical, pharmaceutical, semiconductor, automation, and food and beverage industries; instruments to the laboratory equipment, ultra-precision manufacturing, medical, and test and measurement markets; power quality monitoring and c devices, uninterruptible power supplies, programmable power and electromagnetic compatibility test equipment, and sensors for gas turbines and dashboard instruments; heavy trucks, instrumentation, and controls for the food and beverage industries; and aircraft and engine sensors, power supplies, embedded computing, monitoring, fuel and fluid measurement, and data acquisition systems for aerospace and defense industry.
Recommended Stories
- Five stocks we like better than AMETEK
- Health Care Stocks Explained: Why You Might Want to Invest
- Amazon Is One of the Clearest Buys If the Market Dips Again
- 3 Healthcare Dividend Stocks to Buy
- CoreWeave’s Guidance Cut: A Buying Opportunity in Disguise?
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- Strategy Shares Plunge as Bitcoin Retreats—More Pain Ahead?
Receive News & Ratings for AMETEK Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AMETEK and related companies with MarketBeat.com's FREE daily email newsletter.
